PPHLN1 (NM_016488) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC215736L2V
- LentiORF®
Lenti ORF particles, PPHLN1 (mGFP-tagged) - Human periphilin 1 (PPHLN1), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 10,070.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | PPHLN1 (NM_016488) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | CR; HSPC206; HSPC232 |
Vector | pLenti-C-mGFP |
ACCN | NM_016488 |
ORF Size | 1374 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC215736).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_016488.5 |
RefSeq Size | 3483 bp |
RefSeq ORF | 1377 bp |
Locus ID | 51535 |
MW | 52.6 kDa |
Gene Summary | The protein encoded by this gene is one of the several proteins that become sequentially incorporated into the cornified cell envelope during the terminal differentiation of keratinocyte at the outer layers of epidermis. This protein interacts with periplakin, which is known as a precursor of the cornified cell envelope. The cellular localization pattern and insolubility of this protein suggest that it may play a role in epithelial differentiation and contribute to epidermal integrity and barrier formation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...